Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHX + Cymenol gel vs CHX gel for oral biofilm
NCT06437262Phase 1Completed
- Sponsor
- Universidad de Santiago de Compostela
- Start
- Sep 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of o-Cymen-5-ol in dental plaque (2 arms), sponsored by Universidad de Santiago de Compostela. Primary endpoints: Intragel bacterial viability at 7 hours and Intergel bacterial viability at 7 hours. Started Sep 2022; status: completed.
02
Drugs
o-Cymen-5-ol
03
Conditions
dental plaque
Beyond the preview
Go deeper on NCT06437262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06437262.